ProAssurance reports Q2 net income $21.9M ($0.42 EPS); merger with Doctors Co. on track

PROASSURANCE CORP

2025-Q2 EPS reported $0.31 revenue$548,831,000

Net income $21.9M ($0.42 diluted EPS); operating income $26.8M ($0.52 diluted EPS) for Q2 2025.
Specialty P&C net premiums written stable at $135.9M; renewal premium increases of 10% (cumulative >70% since 2018).
Non-GAAP combined ratio improved 9.5 ppts YoY; net investment income up 6%.
Book value per share $24.80, up $1.31 from year-end; adjusted book value $27.07.
Stockholders approved merger with The Doctors Company; FTC granted early termination; expected close H1 2026.

item 2.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.